A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC
Clinical trial NCT05839197 · UNKNOWN
Trial details
- NCT number
- NCT05839197
- Sponsor
- Wan-Guang Zhang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-05
- Primary completion
- 2025-04-15
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.